Takeda Pharmaceuticals U.S.A., Inc.
Head of Genomics Technologies Group (Director)','1800439','!*!Are you looking for a patient-focused company that will inspire you and support your career? If so, be empowered to take charge of your future at Takeda. Join us as Head Genomics Technologies Group (Director) in our Cambridge office.
Here, everyone matters and you will be a vital contributor to our inspiring, bold mission. As a Head Genomics Technologies Group (Director) working on the Translational and Biomarker Research team, you will be empowered to lead the implementation of genomics technologies and manage a group of scientists and a typical day will include:
The Translational and Biomarker Research (TBR) group at Takeda designs the clinical biomarker and patient characterization strategies, develops and implements clinical biomarkers assays through a network of external laboratories and delivers high quality biomarker, PK, immunogenicity and patient characterization data to support early and late stage clinical programs and reverse translation. TBR is dedicated to technical innovation for clinical application across multiple platform types and investigates novel technologies as needed for clinical goals and patient characterization. TBR biomarker strategies and clinical assays are utilized in all therapeutic areas of Takeda’s focus: Neuroscience, Oncology and Gastrointestinal diseases.
We are seeking a senior leader for the genomics technologies group in TBR. This group is responsible for the development and implementation of nucleic acid technology platforms for clinical assays and patient characterization strategies and delivery of high quality data for clinical use and reverse translation. Working within a completely externally facing model, platform expertise includes DNA and RNA technologies to identify transcriptomic, mutational and epigenetic variations. Applications range from highly targeted genotyping assays to multiomic longitudinal sequencing studies. Techniques and methods are tailored to the needs of the clinical trial utilizing nucleic acids from a variety of sources including the tumors, cfDNA, exosomes and the microbiome. The head of this group will lead a group of scientists to establish high level experimental plans including analysis for genomics assay development and utilization in clinical trials, oversee assay development and outsourcing to vendor labs according to the budget and timelines, deliver high quality data and develop long-term strategy investments in innovative technologies.
Direct implementation of genomics technologies in clinical trials for patient characterization and as biomarkers, integrating technical excellence and analytical strategy
Manage a group of scientists to support clinical programs through the development and outsourcing of genomics assays to external vendors, ensure that clinical study timelines for data delivery are met and data is high quality and meets clinical laboratory standards and regulatory and legal requirements
Establish collaborations and effectively communicate TBR genomic capabilities within the global Takeda organizations to advance the use of genomics technologies for forward and reverse translation.
Partner with computational biologists and statisticians to establish priorities for clinical genomics data analysis, management, database build and internal and external supporting resources. Drive identification and use of innovative analytical methods based on clinical data needs
Subject matter expert for clinical application of genomics technologies and analytical tools
Drive technical innovation for patient characterization as platforms evolve and improve','!*!EDUCATION, EXPERIENCE, BEHAVIOURAL COMPETENCIES AND SKILLS:
PhD in bioinformatics, molecular biology, computational biology or a related field, with 5 years of experience in multiple genomics technologies and applications
Experience with processing and analysis of next-generation sequencing and other genomic data
Knowledge of genomics applications in multiple disease areas (oncology, neuroscience and gastrointestinal) and able to articulate questions which can be answered from complex data sets
Proven track record of developing strategies and leading the implementation of genomics technologies that are an integral part of drug development and disease characterization
Experience in performing due diligence and implementing innovative technology platforms as part of an overall technology development strategy
Demonstrated ability to establish effective collaborative relationships with cross functional scientific and clinical teams
Strong communication and organizational skills
WHAT TAKEDA CAN OFFER YOU:
401(k) with company match and Annual Retirement Contribution Plan
Company match of charitable contributions
Health & Wellness programs including onsite flu shots and health screenings
Generous time off for vacation and the option to purchase additional vacation days
Community Outreach Programs
Empowering Our People to Shine
Learn more at takedajobs.com.
Takeda is an EEO employer of minorities, women, disabled, protected veterans, and considers qualified applicants with criminal histories in accordance with applicable laws. For more information, visit http://www.takeda.us/careers/EEO_Policy_Statement.aspx
No Phone Calls or Recruiters Please.
#LI-MB1','Research and Development','US-MA-Cambridge','','Full-time','Feb 13, 2018','Head of Genomics Technologies Group (Director)
Takeda Pharmaceuticals U.S.A., Inc.
Website : http://www.takeda.us/
As a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) is among the top 15 pharmaceutical companies in the United States. TPUSA was founded in 1998 to accelerate Takeda's global expansion into the U.S. market. Takeda's U.S. clinical development activities are conducted via Takeda Development Center Americas, Inc., which has a robust pipeline of compounds in multiple therapeutic areas including metabolic and cardiovascular diseases, central nervous system, respiratory and immunology, oncology and general medicine. Striving toward better health is at the center of everything we do. Takeda is enjoying tremendous growth as an emerging global leader in the pharmaceutical industry, but remains ever mindful of our commitment to serve people worldwide by striving toward better health through leading innovation in medicine.The spirit of our commitment extends to our employees, partners and the larger community.